scholarly journals Serum Levels of the Adipokine Adipocyte Fatty Acid-binding Protein Are Increased in Preeclampsia

2008 ◽  
Vol 21 (5) ◽  
pp. 582-586 ◽  
Author(s):  
M. Fasshauer ◽  
J. Seeger ◽  
T. Waldeyer ◽  
S. Schrey ◽  
T. Ebert ◽  
...  
Keyword(s):  
Fatty Acid ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Serum Levels ◽  
Fatty Acid Binding ◽  
Acid Binding Protein

scholarly journals Association Between Serum Levels of Adipocyte Fatty Acid-binding Protein and Free Thyroxine

Medicine ◽  
2015 ◽  
Vol 94 (41) ◽  
pp. e1798 ◽  
Author(s):  
Fen-Yu Tseng ◽  
Pei-Lung Chen ◽  
Yen-Ting Chen ◽  
Yu-Chao Chi ◽  
Shyang-Ron Shih ◽  
...  
Keyword(s):  
Fatty Acid ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Serum Levels ◽  
Free Thyroxine ◽  
Fatty Acid Binding ◽  
Acid Binding Protein

Heart type fatty acid binding protein in relation to pharmacologic scintigraphy in coronary artery disease

2012 ◽  
Vol 50 (2) ◽  
Author(s):  
Eftihia Sbarouni ◽  
Panagiota Georgiadou ◽  
Maria Koutelou ◽  
Mihas Constantinos ◽  
Antigoni Chaidaroglou ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Fatty Acid ◽  
Coronary Artery ◽  
Stress Testing ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Serum Levels ◽  
Fatty Acid Binding ◽  
Acid Binding Protein ◽  
Artery Disease

AbstractHeart-type fatty acid-binding protein (H-FABP) is a marker of myocardial necrosis, but whether it increases during myocardial ischemia is not known. This study investigated whether serum levels of H-FABP change during adenosine stress testing and nuclear imaging in patients with stable coronary artery disease.Thirty stable patients with established coronary artery disease on their medications were studied. Sampling was performed before the stress test, at the end of adenosine infusion, as well as 1, 2 and 3 h after the completion of the infusion.No difference in H-FABP serum levels were found at the five pre-specified time points in the overall group (p=0.99); furthermore, there was no significant difference regardless of the test result – positive (p=1) or negative (p=0.98).It is concluded that H-FABP does not change significantly during pharmacologic stress testing in patients with known coronary artery disease and there is no difference whether there is inducible ischemia or not.

scholarly journals Serum levels of fatty acid binding protein 4 and fat metabolic markers in relation to catecholamines following exercise

2017 ◽  
Vol 50 (16-17) ◽  
pp. 896-902 ◽  
Author(s):  
Tatsuya Iso ◽  
Hiroaki Sunaga ◽  
Hiroki Matsui ◽  
Shu Kasama ◽  
Naomi Oshima ◽  
...  
Keyword(s):  
Fatty Acid ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Serum Levels ◽  
Metabolic Markers ◽  
Fatty Acid Binding ◽  
Acid Binding Protein

Serum Levels of Adipocyte Fatty Acid–Binding Protein Are Decreased in Chronic Pancreatitis

Pancreas ◽  
2012 ◽  
Vol 41 (8) ◽  
pp. 1230-1234 ◽  
Author(s):  
Lena Selig ◽  
Matthias Reiche ◽  
Thomas Ebert ◽  
Doreen Krehl ◽  
Susan Kralisch ◽  
...  
Keyword(s):  
Chronic Pancreatitis ◽  
Fatty Acid ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Serum Levels ◽  
Fatty Acid Binding ◽  
Acid Binding Protein

scholarly journals Serum Levels of Fatty Acid Binding Protein 5 Decreased in Squamous Cell Lung Carcinoma

2014 ◽  
Vol 3 (4) ◽  
pp. 222-7
Author(s):  
Mohammad Ali Ghayyoumi ◽  
Zahra Mojtahedi ◽  
Mahsa Mansouri ◽  
Narges Montazari ◽  
Hamidreza Sahraian ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Fatty Acid ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Serum Levels ◽  
Fatty Acid Binding ◽  
Acid Binding Protein ◽  
Significant Difference

Background: The aberrant expression of Dickkopf-1 (DKK1), triose phosphate isomerase (TPI) and fatty acid binding-protein 5 (FABP5) in lung cancer tissues and their presence in secretome of lung cancer cell lines were reported. Here, serum levels of these molecules in lung cancer patients were compared to those in a healthy control group.Materials and Methods: The patients’ group consisted of 50 newly diagnosed male patients with a mean age of 65.3±11.5 years (27 squamous cell carcinoma (SCC), 7 adenocarcinoma, and 16 small cell carcinoma). Thirty eight apparently healthy men (mean aged 65.1±11.4) served as the control group. ELISA was employed for quantification.Results: Comparison between patients and controls revealed no significant difference, although FABP5 level was lower in patients (3.2 vs. 4.8; p=0.09). Analysis of each type of lung cancer with controls indicated that patients with SCC had significantly lower levels of FABP5 than in controls (2.7 vs. 4.8 ng/ml; P=0.03).Conclusion: Comparison between patients and controls revealed no significant difference, although FABP5 level was lower in patients (3.2 vs. 4.8; p=0.09). Analysis of each type of lung cancer with controls indicated that patients with SCC had significantly lower levels of FABP5 than in controls (2.7 vs. 4.8 ng/ml; P=0.03).[GMJ. 2014;3(4):222-7]

Sign in / Sign up

Export Citation Format

Share Document